Atlas Trials

Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population

Clinical trial NCT03962881 · UNKNOWN

Trial details

NCT number
NCT03962881
Sponsor
Shanxi Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis B Vaccine
Start date
2019-05-25
Primary completion
2020-02-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.